Skip to main content
Daniel Grossman

Daniel Grossman, MD

ANSIRH Director

Daniel Grossman focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa, as well as evaluating the impact of integrating reproductive health and HIV services. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. As a faculty member in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, Dan performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dan received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.

The latest research

See all
January 13, 2021

Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial

Dragoman MV Grossman D Nguyen MH Habib N Kapp N Tamang A Bessenaar T Duong LD Gautam J Yoko JL Hong M Gulmezoglu M. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial. January 2021. Contraception, 103(3):163-170.